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A fundamental question in developmental biology is
whether there are mechanisms to detect stem cells
with mutations that, although not adversely affecting
viability, would compromise their ability to contribute
to further development. Here, we show that cell
competition is a mechanism regulating the fitness
of embryonic stem cells (ESCs). We find that ESCs
displaying defective bone morphogenetic protein
signaling or defective autophagy or that are tetra-
ploid are eliminated at the onset of differentiation
by wild-type cells. This elimination occurs in an
apoptosis-dependent manner and is mediated by
secreted factors. Furthermore, during this process,
we find that establishment of differential c-Myc
levels is critical and that c-Myc overexpression is
sufficient to induce competitive behavior in ESCs.
Cell competition is, therefore, a process that allows
recognition and elimination of defective cells during
the early stages of development and is likely to play
important roles in tissue homeostasis and stem cell
maintenance.
INTRODUCTION
Embryonic stem cells (ESCs) are the pluripotent counterparts
of the preimplantation epiblast and are an invaluable model
for understanding the first steps of mammalian development.
These cells show rapid self-renewal and retain the potential
to contribute to all derivatives of the three germ layers: endo-
derm, mesoderm, and ectoderm. Over the past few years,
much has been learned about the mechanisms controlling ESC
pluripotency (Nichols and Smith, 2009), but little is known
regarding the mechanisms that control cell survival at the
pluripotent stage and during the first stages of embryonic
differentiation. It has been particularly hard to uncover whether
there is any surveillance mechanism that detects cells thatDcarry mutations that, although they would not adversely affect
viability, would compromise their ability to contribute to further
development. In the mouse embryo, apoptosis peaks just
prior to the onset of gastrulation (Coucouvanis and Martin,
1999; Manova et al., 1998; Spruce et al., 2010). In addition to
this, coincident with the start of embryonic differentiation, the
embryo becomes hypersensitive to DNA damage induced
by low-dose irradiation (Heyer et al., 2000). This suggests that,
during these stages, cellular fitness and viability are likely to be
tightly monitored.
Cell competition is a type of cell-cell interaction first studied in
Drosophila, where the coexistence of two cell populations with
different metabolic properties or growth rates results in the
growth of the stronger population at the expense of the weaker
one. This process of recognition and elimination of vulnerable,
mispatterned, or abnormal cells during tissue growth has been
proposed to play important roles in tissue homeostasis, organ
size control, stem cell maintenance, and the expansion of pre-
cancerous cell fields (de Beco et al., 2012; Levayer and Moreno,
2013; Wagstaff et al., 2013). Here, we find that ESCs that
display defective bone morphogenetic protein (BMP) signaling
or defective autophagy or are tetraploid are eliminated at the
onset of differentiation in an apoptosis-dependent manner,
only in the presence of wild-type cells. Furthermore, we show
that c-Myc is a key mediator in this process. We argue that
these observations are remarkably reminiscent of what has
been described as cell competition in other systems. Our data
therefore demonstrate an involvement of cell competition in
regulating cellular fitness during the first steps of embryonic
differentiation in mammals.RESULTS
Cells with Defective BMP Signaling Are Eliminated
in the Presence of Wild-Type Cells
BMP signaling is required for maintaining self-renewal and
pluripotency of ESCs (Ying et al., 2003) and of the mouse post-
implantation epiblast (Di-Gregorio et al., 2007). In embryos
carrying a null mutation for Bmpr1a, the main type I BMP
receptor during early postimplantation development, the entireevelopmental Cell 26, 19–30, July 15, 2013 ª2013 The Authors 19
Figure 1. Cells with Defective BMP Signaling Are Eliminated in the Presence of Wild-Type Cells
(A) High levels of apoptosis in Bmpr1a/ cells in Bmpr1a/fx;Mox2Cre+/ embryos (n = 5/7). act-Casp3, cleaved (activated) Caspase3.
(B) Phosphorylation of Smad1/5/8 in the described media (left) and Id gene activation in BMP4 + Lif (right) are decreased in Bmpr1a/ ESCs. PCNA, proliferating
cell nuclear antigen.
(C) Time-lapse imaging of cocultured control and Bmpr1a/-GFP ESCs.
(D) Growth curves (left) and ratio (right) of control to Bmpr1a/ ESCs show that Bmpr1a/-GFP ESCs are outcompeted when cultured with control cells in
N2B27. A minimum of three independent experiments were performed, and the average ± SEM was plotted. t, time. **p < 0.005, Student’s paired t test.
See also Figure S1 and Table S1.
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2007). However, in mosaic Bmpr1a/ embryos, mutant cells
are capable of contributing to all germ layers, suggesting that
they have no autonomous defect during the first steps of germ
layer differentiation (Davis et al., 2004; Di-Gregorio et al.,
2007). Careful inspection of Bmpr1a/ mosaics generated
with the Mox2-Cre deletor line revealed that a proportion of
mutant cells were being eliminated by apoptosis at the epiblast20 Developmental Cell 26, 19–30, July 15, 2013 ª2013 The Authorsstage of postimplantation development (Figure 1A). In the
Drosophila wing, cells that carry a mutation in the Bmpr1a
homolog Thick veins (Tkv) have a competitive disadvantage
over wild-type cells and are eliminated by apoptosis (Burke
and Basler, 1996). Given that ESCs have proven to be a remark-
able model for the first steps of differentiation, we turned to
this system to test if the elimination of Bmpr1a null cells was
due to the presence of wild-type cells.
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Cell Competition Monitors Stem Cell FitnessBmpr1a/ ESCs can still transduce BMP signaling, but the
level of activation of this pathway is reduced compared to that
of control cells (Figure 1B). In spite of this, as we have
previously reported (Di-Gregorio et al., 2007), Bmpr1a/ ESCs
have a similar pluripotent status to that of wild-type cells (Fig-
ure S1 available online). To analyze the behavior of Bmpr1a/
ESCs in the presence of wild-type cells, we labeled the mutant
cells with green fluorescent protein (GFP), and the two cell
types were cocultured. N2B27 media was used for these exper-
iments, as this allows ESCs cells to progress into a state that
transcriptionally resembles the postimplantation epiblast (Fig-
ure S2A) (Brons et al., 2007; Tesar et al., 2007). Time-lapse
analysis revealed that, over a 4-day period, the proportion of
Bmpr1a/-GFP cells was dramatically reduced in these cul-
tures (Figure 1C). To establish if this was due to the presence
of wild-type cells, we cultured Bmpr1a/-GFP ESCs and
control ESCs separately or together. Analysis of their growth
curves and of the ratio of control ESCs to Bmpr1a/ ESCs
(obtained by flow cytometry) in each of these conditions revealed
that, from day 3 in N2B27, the total number of Bmpr1a/-GFP
ESCs decreased specifically in coculture (Figure 1D). This led
to a significant increase in the proportion of control cells at
days 3 and 4 of coculture, compared to separate populations
(Figure 1D; Table S1). Calculation of the growth rate for each
cell type in separate and coculture conditions indicated that
accompanying the decrease in numbers of Bmpr1a/-GFP
ESCs was a significant increase in the growth rate of control
cells (Figure 2A; Table S1), suggesting that they undergo
compensatory proliferation. When unlabeled Bmpr1a/ ESCs
were cultured with E14 (control) GFP-labeled cells to exclude
a possible deleterious effect of GFP, we observed a similar
phenomenon (Figures S2B and S2C; Table S1).
To address whether the decrease in the numbers of
Bmpr1a/ ESCs was due to apoptosis, we analyzed whether
the addition of the pancaspase inhibitor ZVAD-FMK could pre-
vent the elimination of Bmpr1a/ ESCs in coculture. We ob-
served that, at day 3, mixed colonies exhibited large amounts
of cellular debris of Bmpr1a/-GFP ESCs that could be visual-
ized as punctuate dots of GFP by confocal microscopy (Figures
2B and S2D). However, addition of ZVAD-FMK from the second
day of culture abolished the elimination of Bmpr1a/-GFP cells
and led to the disappearance of GFP-positive cellular debris in
coculture (Figure 2B; Table S1).
To investigate the possibility that the elimination of
Bmpr1a/ ESCswas due to selection against a specific lineage,
we analyzed the expression of lineage-specific markers
in Bmpr1a/-GFP and control ESCs. We observed that
Bmpr1a/-GFP ESCs in coculture showed an expression pro-
file of mesoderm, endoderm, neural, and epidermal marker
gene expression that was very similar to when theywere cultured
as a homogeneous population (Figure S2E). Together, these
results indicate that Bmpr1a/ ESCs are eliminated by
apoptosis when in the presence of wild-type cells and that this
elimination is not specific to any particular lineage.
Elimination of Bmpr1a–/– Cells Is Dependent on the
Onset of Differentiation
Bmpr1a/ embryos only display defects at postimplantation
stages (Di-Gregorio et al., 2007), and in mosaics, a proportionDof Bmpr1a/ cells are eliminated by apoptosis at 6.5 days post-
coitum (dpc) (Figure 1A). We therefore asked if the elimination
of Bmpr1a/ cells was dependent on exit of the ground state
of pluripotency, which is thought to exist in preimplantation
embryos and ESCs (Nichols and Smith, 2009). We first analyzed
whether the elimination of Bmpr1a/ cells occurred when
these cells were differentiated to epiblast stem cells (EpiSCs).
When this was done, we observed that the total numbers of
Bmpr1a/ ESCs decreased from the third day of coculture
with control cells in EpiSC media (N2B27 containing Activin
and fibroblast growth factor [FGF]) (Brons et al., 2007; Tesar
et al., 2007) but not when they were cultured alone in these
conditions (Figure 2C). We then analyzed what occurred when
exit of pluripotency was suppressed by culturing the cells in
serum plus Lif, BMP4 plus Lif, or in 2i (a MEK inhibitor and a
GSK3b inhibitor). Interestingly, when we analyzed the ratios of
control ESCs to Bmpr1a/ ESCs in all of these conditions,
we observed that they were similar for cells grown separately
or in coculture (Figure 2D; Table S1). This indicates that,
under conditions that maintain pluripotency, the elimination
of Bmpr1a/ ESCs is abolished and, therefore, that the
outcompetition of these cells only occurs when differentiation
has been initiated.
Secreted Factors Regulate the Elimination
of Bmpr1a–/– Cells
Given that initiation of differentiation is dependent on a wide
array of growth factors, we first tested whether the elimination
ofBmpr1a/ cells requires cell contact. To test this, we cultured
Bmpr1a/ and control ESCs on Corning Transwell polycarbon-
ate membrane cell culture inserts. In this system, cells of one
genotype are cultured on the base of the well, and those of
another genotype are cultured on a filter in an insert that lies
1.2mmover the base of the well. We found that there was no sig-
nificant difference in the numbers of control or Bmpr1a/ ESCs
when these were grown for 4 days with cells of the same geno-
type overlaying them or in the numbers of control cells when they
were grown with overlaying Bmpr1a/ ESCs (Figure 3A). In
contrast, when Bmpr1a/ ESCs were grown with overlaying
control cells, their numbers were significantly lower than those
of the other combinations tested (Figure 3A), indicating that
secreted factors in the shared media must mediate their elimina-
tion. Interestingly, a similar finding has been made for cell
competition inDrosophila (Senoo-Matsuda and Johnston, 2007).
We next asked if the elimination of Bmpr1a/ ESCs was due
to defective BMP signaling. For this, we transfected Bmpr1a/
ESCswith a CAG-Bmpr1a expression cassette (Bmpr1aGOF) and
analyzed their behavior in coculture assays. We found that
restoring BMP signaling in Bmpr1a/ ESCs rescued their elim-
ination in mixed cultures but also led them to induce elimination
of nontransfected Bmpr1a/ ESCs (Figures S3A–S3C; Table
S1). These results indicate that the outcompetition of
Bmpr1a/ ESCs in coculture is due to the deficiency in trans-
ducing BMP signaling.
An attractive model to explain the elimination of Bmpr1a/
ESCs is that defective BMP signaling made Bmpr1a/ ESCs
less capable of competing for limiting amounts of BMPs that
act as a survival factor (Moreno and Basler, 2004; Moreno
et al., 2002). To analyze whether limiting BMP availability wouldevelopmental Cell 26, 19–30, July 15, 2013 ª2013 The Authors 21
Figure 2. ESCs with Defective BMP Signaling Are Eliminated by Apoptosis upon Exit of the Ground State of Pluripotency
(A) Growth rates (in cell doublings per day) of control and Bmpr1a/ ESCs between days 3 and 4 of culture indicate that, while Bmpr1a/ ESCs are eliminated,
control cells undergo compensatory proliferation. Sep., separate culture; Co-Cul., coculture.
(B) Ratio obtained by flow cytometry and confocal images of Bmpr1a/ and control cells indicates that addition between days 2 and 4 of coculture of the
pancaspase inhibitor ZVAD-FMK blocks the elimination of Bmpr1a/ ESCs. DMSO, dimethyl sulfoxide.
(legend continued on next page)
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Figure 3. Elimination ofBmpr1a–/– ESCs De-
pends on Secreted Factors
(A) Assays using Corning Transwell inserts indicate
that the growth of Bmpr1a/ ESCs is inhibited
when these cells are grown with overlaying control
cells in N2B27. Cell numbers refer to the cells
growing underneath the insert; the genotype of
the cells growing on the insert is indicated in
brackets.
(B) Plot of the ratio of control to Bmpr1a/ ESCs
cultured as separate populations or cocultured
in the presence of Noggin (p = 0.15), Bmpr1a-Fc
(p = 0.48), BMP4 (p = 0.97), BMP7 (p = 0.51),
FGF4 (p = 0.33), FGF5 (p = 0.93), and Lif from day 0
(p = 0.0001) or from day 2 (p = 0.06). The plot
shows that only when Lif is added from day 0 of
coculture is the outcompetition of Bmpr1a/
ESCs significantly blocked.
(C) Western blot showing that Lif is less efficient
in triggering Stat3 phosphorylation once differen-
tiation is initiated. A minimum of three independent
experiments were performed, and the average ±
SEM was plotted. pStat3, phosphorylated Stat3.
**p < 0.005, Student’s paired t test.
See also Figure S4 and Table S1.
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cultures of Bmpr1a/ and control ESCs in the presence of the
BMP antagonist Noggin and of the fusion protein BMPR1A-FC,
a soluble dominant-negative form of BMPR1A. To test whether
providing an excess of BMPs would rescue the disadvantage
of Bmpr1a/ ESCs, we used either BMP4 or BMP7. We
observed that, after 3 days of coculture in N2B27, Noggin
decreased Smad1/5/8 phosphorylation in control and
Bmpr1a/ ESCs. In contrast to this, BMP4 increased Smad1/
5/8 activation in control, but not Bmpr1a/, ESCs. This led to
an overall increase in the difference of BMP signaling between
control and Bmpr1a/ ESCs (Figures S4A and S4B). In spite
of this, BMP4, BMP7, Noggin, and BMPR1A-FC did not signifi-
cantly alter the ratio of Bmpr1a/ to control ESCs either sepa-
rately or as cocultures (Figure 3B). These data suggest that,
although defective BMP signaling leads to the elimination of
mutant ESCs, cells are not competing for limiting amounts of
BMPs, and the relative level of BMP signaling is not triggering
their elimination.
Given these observations, we asked if other signaling path-
ways could be mediating the cell nonautonomous elimination
of Bmpr1a/ ESCs. Given that inhibition of FGF signaling and
BMP plus Lif are two conditions that block the elimination of
Bmpr1a/ ESCs (Figure 2D), we asked whether excess FGF4,(C) Growth curves (left) and ratios (right) of control and Bmpr1a/ ESCs showing that the elimination of mu
(D) Ratio of control to Bmpr1a/ ESCs showing that the outcompetition of Bmpr1a/-GFP ESCs is preve
PD0325901. A minimum of three independent experiments were performed, and the average ± SEMwas plot
variance (ANOVA) followed by Tukey’s test.
See also Figures S2 and S3 and Table S1.
Developmental Cell 26, 1FGF5, or Lif affected this process. Inter-
estingly, we observed that while FGF4
and FGF5 had little effect on the elimina-
tion of Bmpr1a/ ESCs, Lif completely
abolished their competitive disadvantagein coculture (Figure 3B; Table S1). This suggests that the
signaling events downstream of Lif are a key element to the
mechanism by which cells sense the defective status of
Bmpr1a/ ESCs. To address if the activity of Lif was specific
to the ground state of pluripotency, we tested the effect of Lif
when added from day 2 of coculture in N2B27. We observed
that once differentiation had been initiated, Lif only partially
rescued the elimination ofBmpr1a/ ESCs (Figure 3B). Interest-
ingly, analysis of the expression of components of the Lif
pathway in ESCs after a 3 day culture in N2B27 indicated that
the levels of gp130 and Stat3 were reduced (Figure S4C).
Furthermore, we observed that Lif was also less efficient at trig-
gering Stat3 phosphorylation when Bmpr1a/ ESCs were
cultured in N2B27 (Figure 3C). This indicates that, once ESCs
have exited the ground state of pluripotency, Lif is less efficient
at signaling and suggests that, although events downstream
of Lif may be mediating the elimination of Bmpr1a/ ESCs,
Lif itself is not directly involved in cell competition.
Autophagy-Deficient and Tetraploid ESCs
Are Also Eliminated by Wild-Type Cells
Our finding that cells with defective BMP signaling are eliminated
by wild-type cells prompted us to ask if this also occurred with
cells carrying other defects. Autophagy is an intracellulartant cells occurs under EpiSC culture conditions.
nted by FCS + Lif, BMP4 + Lif, 2i, CHIR99021, or
ted. *p < 0.05, and **p < 0.01; a one-way analysis of
9–30, July 15, 2013 ª2013 The Authors 23
Figure 4. Autophagy-Deficient and Tetra-
ploid ESCs Are Eliminated by Cell Competi-
tion
(A) Growth curves and plots of the ratio of control
to Atg5/ ESCs in separate culture or coculture.
(B) Growth curves and plots of the ratio of control
to tetraploid ESCs in separate culture or coculture.
Both (A) and (B) indicate that both autophagy
deficiency and tetraploidy induce cell competition.
(C) Histograms for Annexin V levels in control and
tetraploid ESCs in separate culture or coculture in
EpiSC media.
(D) Immunostaining for cleaved-caspase 3 in chi-
meras generated with tetraploid-GFP ESCs (n =
10).
Both (C) and (D) indicate that the tetraploid ESCs
are eliminated by apoptosis both in vitro and
in vivo. A minimum of three independent experi-
ments were performed, and the average ± SEM
was plotted. **p < 0.005, Student’s paired t test.
See also Figure S5 and Table S1.
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Cell Competition Monitors Stem Cell Fitnessdegradation pathway that plays a pleiotropic role in the protec-
tion and maintenance of cellular life as well as in the response
to starvation. Atg5 is a critical component of the autophagy
pathway. Atg5-deficient ESCs are defective in ATP metabolism
and, although they display apparently normal growth, upon
differentiation are unable to engulf apoptotic cells (Qu et al.,
2007). When control and Atg5/ ESCs were cultured for
4 days in N2B27, we observed that, from the third day of culture,
the numbers of Atg5/ ESCs decreased specifically when
cocultured with control cells (Figure 4A; Table S1). Interestingly,
this competitive elimination was not observed when Atg5/
ESCs were cocultured with Bmpr1a/ ESCs (Figure S4D;
Table S1), suggesting that ESCs must be capable of measuring
their relative cellular fitness.
Elimination of polyploid cells from a normal genetic environ-
ment has been shown to occur in vivo (Eakin et al., 2005). In24 Developmental Cell 26, 19–30, July 15, 2013 ª2013 The Authorstetraploid (or 4n) chimeras, 4n cells can
be found in the epiblast at 6.5 dpc but
are lost from this tissue thereafter. For
this reason, we asked if tetraploid ESCs
could also be subject to competition
when cultured with diploid (or 2n) cells.
Analysis of the growth rate of 4n ESCs
indicated that they proliferated at a con-
stant rate, but this proliferation was
significantly lower than control cells
(Figure 4B). In contrast to this, when
4n ESCs were cocultured with diploid
ESCs, their numbers decreased from
the second day of coculture (Figures 4B
and 4C; Table S1). This decrease was
found to be due to apoptosis, as tetra-
ploid cells showed higher levels of
annexin V staining than control cells and
these levels were significantly higher in
the cocultured condition compared to
when these cells were cultured sepa-rately (Figure 4C). To test whether a similar phenomenon
occurred in vivo, we generated chimeras using GFP-labeled
tetraploid ESCs. We found that, at 6.5 dpc, the vast majority of
tetraploid cells also showed cleaved-caspase 3 staining, indi-
cating that, in the embryo, these cells were also eliminated by
apoptosis (Figure 4D).
A possible explanation for the elimination of tetraploid or
Atg5/ ESCs is that they have defective BMP signaling. To
address whether this could be the case, we analyzed the ability
of both these lines to respond to BMP4 after a 3 day culture in
N2B27, when the elimination of defective cells occurs. We
observed that, after stimulation with BMP4, both tetraploid and
Atg5/ ESCs induced robust Smad1/5/8 phosphorylation,
indicating that BMP signaling was normal in these cells
(Figure S5A). We next analyzed if defective autophagy could
be the cause for the elimination of Bmpr1a/ or tetraploid cells.
Figure 5. Establishment of Differential
c-Myc Levels Is Critical for the Elimination
of Defective ESCs
(A and B) In (A), western blot analysis and quanti-
fication of relative c-Myc/PCNA intensity indicate
that c-Myc protein expression is significantly
downregulated in Bmpr1a/ ESCs at day 3 of
coculture with control cells, but (B) shows that
this difference is abolished by Lif and MEK inhibi-
tion using PD0325901.
(C and D) c-Myc levels are also lower in (C) Atg5/
ESCs and in (D) tetraploid ESCs when cocultured
with control ESCs. Cells in coculture were sorted
by FACS based on GFP expression prior to
analysis. A minimum of three independent exper-
iments were performed, and the average ± SEM
was plotted. *p < 0.05, and **p < 0.01; a one-way
ANOVA was followed by Tukey’s test.
See also Figure S5.
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from its LC3-I to its LC3-II isoform upon the induction of
autophagy, and p62, a protein that is degraded during auto-
phagy. We observed that, after a 3 day culture in N2B27,
Bmpr1a/ and tetraploid ESCs displayed a similar ratio of
LC3-I to LC3-II expression and levels of p62 expression similar
to that of control ESCs, indicating that they were not defective
in autophagy (Figure S5B).
A third possibility is that defective ploidy could be a defect
common to the eliminated cells. This possibility can be
discarded, as Bmpr1a/ ESCs have a normal karyotype (data
not shown) and the elimination of these cells can be rescued
by reintroducing into them the Bmpr1a gene (Figures S3A–
S3C). Together, these data point to a general mechanism
that is monitoring ESC fitness upon the onset of differentia-
tion in a non-cell-autonomous fashion rather than to a defectDevelopmental Cell 26, 1that is common among Bmpr1a/,
Atg5/, and tetraploid ESC lines.
c-Myc Is a Key Mediator of the
Elimination of Defective ESCs
The MYC family of transcription factors
has been implicated in a variety of bio-
logical processes, including apoptosis
and cell cycle regulation (Dang, 2012).
Furthermore, in Drosophila, d-Myc has
been shown to be a key regulator of cell
competition in the wing epithelium and
in the developing ovary (de la Cova
et al., 2004; Moreno and Basler, 2004;
Rhiner et al., 2009). In ESCs, c-Myc acts
downstream of Lif in the control of self-
renewal (Cartwright et al., 2005; Singh
and Dalton, 2009), and for these reasons,
we addressed the possible involvement
of c-Myc in the elimination of Bmpr1a/
ESCs. Cells of different genotypes were
sorted by fluorescence-activated cell
sorting (FACS) on the basis of their GFPexpression, and either messenger RNA (mRNA) or protein were
isolated. Analysis of c-Myc mRNA levels revealed that these
were similar in N2B27 for both Bmpr1a/-GFP and control
ESCs, regardless of being in coculture or not (Figure S6A). In
contrast to this, c-Myc protein levels were significantly increased
specifically in wild-type ESCs only when cocultured with
Bmpr1a/-GFP cells (Figure 5A). This suggests that
differential c-Myc protein levels may be a key event in the
elimination of Bmpr1a/ ESCs. To test this, we first analyzed
what occurred when these assays were performed in the pres-
ence of Lif or of MEK inhibition, two conditions that prevent
the elimination of Bmpr1a/ ESCs (Figure 2). We observed
that both these treatments abolished the differential c-Myc
protein levels found between control and Bmpr1a/-GFP
ESCs (Figure 5B). Next, we analyzed what occurred in the
cocultures of Atg5/ or tetraploid-GFP ESCs with control cells9–30, July 15, 2013 ª2013 The Authors 25
Figure 6. c-Myc Is a Key Mediator of the Elimination of Defective ESCs
(A and B) WISH in (A) and immunostaining in (B) show that c-Myc is heterogeneously expressed in embryos at 6.5 dpc but that this expression is downregulated
from the embryonic region by 7.5 dpc. The lower image is a magnification of the region highlighted by the square.
(C) TUNEL staining indicates that cell death peaks at 6.5 dpc in the embryo.
(D) Double staining for TUNEL and c-Myc shows that those cells that are dying (white arrows) show low levels of c-Myc expression.
(E) Growth curves and plot of the ratio of c-MycER and control ESCs when grown for 3 days in N2B27 and then treated with tamoxifen for 3 days in separate and
coculture conditions, showing how c-Myc overexpression induces the elimination of control cells. Aminimum of three independent experiments were performed,
and the average ± SEM was plotted. **p < 0.005, Student’s paired t test.
See also Figure S6 and Table S1.
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with control cells, they downregulated c-Myc expression (Fig-
ures 5C and 5D).
These observations prompted us to address if there was any
correlation between c-Myc levels and cell death in vivo. Analysis
of c-Myc mRNA and protein expression showed that it was26 Developmental Cell 26, 19–30, July 15, 2013 ª2013 The Authorsheterogenous in embryos 6.5 dpc but was absent from the
epiblast 7.5 dpc (Figures 6A and 6B). Interestingly, a similar
pattern was observed for cell death, as high levels were
observed at 6.5 dpc and dramatically reduced by 7.5 dpc (Fig-
ure 6C). Furthermore, costaining for cell death (using TUNEL)
and c-Myc revealed that, in the epiblast 6.5 dpc, those cells
Developmental Cell
Cell Competition Monitors Stem Cell Fitnessthat were dying preferentially showed low levels of c-Myc
expression (Figure 6D). These results suggest that the establish-
ment of differential levels of c-Myc is a common mechanism
regulating the elimination of aberrant ESCs.
To test this hypothesis further, we analyzed if c-Myc overex-
pression is sufficient to induce the elimination of wild-type cells.
For this, we generated a tamoxifen-inducible c-Myc overex-
pression line and analyzed its behavior when cocultured with
E14-GFP ESCs. Overexpression of c-Myc had been reported
to maintain cells in the pluripotent state (Cartwright et al.,
2005), and given that we have shown that cell competition only
occurred once ESCs had initiated differentiation (Figure 2),
we first allowed cells to differentiate and then stimulated
c-Myc activation. Control cells carrying a tamoxifen-inducible
c-Myc construct (E14-cMycER) and E14-GFP cells were cocul-
tured or grown separately for 3 days without tamoxifen,
and then tamoxifen was added for a further 3 days (Figure S6B).
Analysis of the growth curves of E14-cMycER and E14-GFP cells
in each condition indicated that, in the presence of tamoxifen,
E14-cMycER cells grew at a similar rate in both the separate
and coculture conditions (Figure 6E). In contrast to this, E14-
GFP cells changed their behavior from an exponential growth
rate under separate conditions to growth arrest when cocultured
with c-Myc-overexpressing cells (Figure 6E; Table S1), indicating
that they were being eliminated by E14-cMycER cells.
In separate cultures in the presence of tamoxifen, the growth
of E14-cMycER cells was slower than that of E14-GFP ESCs.
Given that we observed that the expression of c-MycER was
heterogeneous in these cultures (data not shown), it is possible
that, in E14-cMycER separate cultures, high-expressing c-Myc
cells are eliminating low-expressing cells. Alternatively, it is
possible that the overexpression of c-Myc is having toxic effects
on these cells. We also observed that, when E14-cMycER cells
were grown without tamoxifen, they were enriched in coculture
compared to when grown separately (Figure S6C; Table S1),
suggesting that the system may be leaky to some degree.
Overall, our data suggest that the establishment of differential
levels of c-Myc is a key event in the elimination of ‘‘unfit’’ embry-
onic stem cells.
DISCUSSION
ESCs possess the unique ability to contribute to all the deriva-
tives of the three germ layers as well as to self-renew in an indef-
inite fashion. In the embryo, their pluripotent counterparts will
give rise to all the different tissues and cell types that compose
the fetus. For this reason, the recognition and elimination of
vulnerable, mispatterned, or abnormal cells is critical not only
for the proper maintenance of the pluripotent stem cell pool
but also for the correct development of the different organs
of the newborn. In the mammalian embryo, the initiation of
gastrulation marks the onset of embryonic differentiation and
is associated with the start of rapid proliferation cycles (Mac
Auley et al., 1993; Snow, 1977; Stuckey et al., 2011a). A potential
cost of this very rapid proliferation rate is the likelihood of a high
production of damaged cells. It is thus expected that, at this
stage, mechanisms are set in place to monitor epiblast fitness.
Apoptosis in the early mouse embryo peaks just prior to the
onset of gastrulation and has been associated to the processDof cavitation (Coucouvanis and Martin, 1999; Manova et al.,
1998; Spruce et al., 2010). Furthermore, coincident with the
start of gastrulation, the embryo also becomes hypersensitive
to DNA damage induced by low-dose irradiation and undergoes
apoptosis (Heyer et al., 2000). Tetraploid cells are eliminated
from the epiblast in 4n:2n chimeras at 6.5 dpc, when gastrulation
is being initiated (Eakin et al., 2005), and here we show that this
occurs by apoptosis. Similarly, we find that cells with defective
BMP signaling or defective autophagy are also eliminated at
the epiblast stage of embryonic development. This suggests
the existence of a general mechanism monitoring stem cell
fitness upon the onset of differentiation in a non-cell-autono-
mous fashion. Our studies indicate that the establishment of
differential levels of c-Myc is crucial to the elimination of defec-
tive cells, leading to the death of those cells with lower c-Myc
levels. This is a feature that occurs both during ESC differentia-
tion and in the epiblast of the 6.5 dpc embryo. Interestingly,
c-Myc expression is reduced when the ground state of pluripo-
tency is captured using GSK3b and MEK inhibition (Ying et al.,
2008). Given that blocking GSK3b activity increases c-Myc
stability in ESCs (Cartwright et al., 2005), this suggests that the
MEK inhibitor must decrease c-Myc levels in 2i. We find that
MEK inhibition blocks the elimination of Bmpr1a/ ESCs;
therefore, one possible reason for why these cells are not elimi-
nated in the ground state of pluripotency may be this effect of
MEK inhibition on c-Myc levels. Alternatively, the mechanisms
that govern cell death between the naive and primed states of
pluripotency may differ.
Our findings are also of relevance to the tetraploid com-
plementation experiments, where, to test the developmental
potential of ESCs, they are injected into tetraploid embryos. In
these chimeras, 4n cells can be found in the epiblast at
6.5 dpc (Eakin et al., 2005) but very rarely contribute to the
embryonic tissue after 9.5 dpc. Our data indicate that this is
because they are eliminated due to their competitive disadvan-
tage. This observation, however, means that the conclusions
from this type of complementation experiments should be
treated with caution. If those ESCs that are used also have
defects that affect their fitness, then it is possible that the
tetraploid cells will persist for longer and, therefore, this will
affect the interpretation of the experiment.
The mode of elimination of defective cells that we observe
here shares several common features with what has been
described as cell competition in Drosophila and other organisms
(de Beco et al., 2012; Levayer andMoreno, 2013; Wagstaff et al.,
2013); for this reason, we argue that cell competition may be
monitoring cellular fitness in the early mammalian embryo.
Together, our data suggest that the elimination of defective
stem cells in the postimplantation epiblast follows sequential
steps (Figure 7). First, a mutual sensing step between cells is
likely to occur, allowing identification of those that present a
lower ‘‘fitness’’ level. Our experiments indicate that this lower
level of cellular ‘‘fitness’’ is a relative rather than an absolute
measure, as defective cells are viable when cultured as a
homogeneous population. Furthermore, our experiments show
that this first step is likely to be mediated, at least in part,
by secreted factors, but we cannot rule out the contribution
of cell-cell contact in further downstream events. Our finding
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Figure 7. Model for HowCell Competition Eliminates Defective Stem
Cells during Early Mammalian Development
A first step during cell competition is the mutual sensing that allows identifi-
cation of those stem cells that present a lower ‘‘fitness’’ level. In response to
the mutual sensing, differential levels of c-Myc are established between ‘‘fit’’
and ‘‘unfit’’ cells. Next, a second ‘‘mutual sensing’’ event occurs that monitors
c-Myc levels, leading to activation of the apoptotic pathway and elimination of
the ‘‘weaker,’’ low c-Myc-expressing stem cells.
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Cell Competition Monitors Stem Cell Fitnesssignaling abilities, growth rates, or metabolic rates is of great
importance for our understanding of how cells behave in a
heterogeneous population, not just how they act as individual
entities.
The second step in the process is that, in response to the
mutual sensing between normal and defective ESCs, differential
levels of c-Myc are established between ‘‘fit’’ and ‘‘unfit’’ cells.
We propose that, once differential levels of c-Myc are estab-
lished, a second ‘‘mutual sensing’’ event occurs, acting as a
second checkpoint to establish the final outcome of the com-
petition. Our data indicate that this second sensing event is
also cell nonautonomous, as control cells are eliminated when
cocultured with c-Myc-overexpressing cells. It is after this
step that activation of the apoptotic pathway and elimination
of the ‘‘weaker’’ cells occurs. We believe that this process of
recognition and elimination of vulnerable, mispatterned, or
abnormal cells during tissue growth is of broad interest, as
it will be fascinating to unravel if it also plays an important role
in tissue homeostasis, organ size control, and stem cell mainte-
nance at later stages of development or in the adult.EXPERIMENTAL PROCEDURES
ESC Culture and Manipulation
E14 ESCs were a gift from Prof. A. Smith (Cambridge University). Bmpr1a/
ESCs were described elsewhere (Di-Gregorio et al., 2007). Atg5/ ESCs
were a gift from Noboru Mizushima (Mizushima et al., 2001). Three tetraploid
ESC lines were used, and these were derived during an electroporation
experiment and determined to have 80 chromosomes by karyotyping. Cells
were maintained following standard conditions and as described elsewhere
(Cambray et al., 2012).28 Developmental Cell 26, 19–30, July 15, 2013 ª2013 The AuthorsCell Competition Assays
After dissociation with Trypsin-EDTA, cells were counted and 4.2 3
104 cells/cm2 plated into 0.1% gelatin-coated six-well plates. Cells were
plated as each genotype separately or as a mixture of control and mutant
ESCs at either a 50:50 or 40:60 ratio depending on the cell type. After plating,
ESCs were incubated for 4 to 5 hr in ESC media without LIF and then washed
and kept in N2B27 ESGRO Basal media (Milipore) for the specified times.
Media were changed daily thereafter. We observed that competition also
occurred when plating in Dulbecco’s modified Eagle’s medium plus serum;
therefore, where indicated, this condition was also used. c-Myc induction
was carried out with 4-hydroxytamoxifen (Sigma) at 10 nM. For analysis of
the growth curves, 4.2 3 104 cells/cm2 were plated for separate cultures
and cocultures, and then cells were counted daily. The cell count graphs
represent the total cell number of each genotype counted. For cells in cocul-
ture, the total number of cells in the mix was counted, and the relative propor-
tion of cells of each genotype was determined by flow cytometry. It is worth
noting that, as control and mutant cells represent only a proportion of the
total cell number in the cocultures, this number is lower than the totals for
each genotype when grown separately.
The graph columns represent the ratio of control to mutant ESCs. For
maximum accuracy, the precise proportion of cells of each genotype present
in coculture was obtained by FACS analysis. For the separate cultures, cells
were trypsinized, mixed in equal volumes, and analyzed by flow cytometry.
Growth Rate Calculations
The growth rate was calculated for each cell type in each condition for the
different time points analyzed using the following equation: growth rate
(in cell doublings per day) equals natural logarithm (final cell number/initial
cell number) divided by the natural logarithm of two. A minimum of three inde-
pendent experiments were performed, and the average ± SEM was plotted.
Caspase Inhibition
We plated 4.0 3 105 cells in a six-well plate and then cultured them from
day 2 for 48 hr in the presence of the pan-caspase inhibitor Z-VAD-FMK
(R&D Systems) at a final concentration of 100 nM. A minimum of three inde-
pendent experiments were performed, and the average ± SEM is plotted.
Growth Factor/Inhibitor Treatments
Cells were cultured in the presence of 1,500 U/ml LIF (Chemicon), 10 ng/ml
BMP4, 25 ng/ml BMP7, 50 ng/ml Noggin, 250 ng/ml BMPR1A-FC, 5 ng/ml
FGF4, 10 ng/ml FGF5 (all from R&D Systems), 1 mM PD0325901 (Sigma), or
3 mM CHIR99021 (Millipore) in serum-free N2B27.
Mice and Embryos
Bmpr1a/fx-; Mox2Cre+/ mice were generated as described elsewhere
(Miura et al., 2006). Mice on a mixed CD1 and 129/Sv background were used
for the cell death and expression analysis. All mice were maintained on a
10 hr-14 hr light-dark cycle. Noon of the day of finding a vaginal plugwas desig-
nated 0.5 dpc. Embryo dissection and chimera generation were carried out as
described elsewhere (Nagy et al., 2003). All mice were maintained and treated
in accordancewith theHomeOffice’s Animals (ScientificProcedures) Act 1986.
Immunostaining and Whole-Mount In Situ Hybridization
Immunostaining was carried out as described elsewhere (Nowotschin et al.,
2013), with minor modifications. Briefly, embryoswere fixed in 4% paraformal-
dehyde (PFA) + 0.1%Tween + 0.01%Triton for 20–30min at room temperature
(RT) and then washed three times in PBS + 0.1% Triton (PBT) for 5 min.
Embryos were permeabilized with 0.4% Triton in PBS for 20 min and then
washed three times for 10 min in PBT. Embryos were then blocked in 2%
horse serum in PBT for 45min at RT and then incubatedwith the antibody over-
night at 4C in (1:2) blocking solution in PBS. Antibodies used were 488-con-
jugated rabbit anti-GFP (1:300; Invitrogen), rabbit anti-cleaved caspase 3
(1:400; Cell Signaling), and rabbit anti-c-Myc (1:250; Abcam Y69 clone). Phal-
loidin-TRITC (Sigma) was used at 1:100. Whole-mount in situ hybridization
(WISH) was carried out as described elsewhere (Stuckey et al., 2011b).
TUNEL and c-MYC Staining on Embryos
TUNEL cell death staining was carried out according to manufacturer’s con-
ditions (Promega DeadEnd Fluorometric TUNEL System), with the following
modifications. Once dissected, embryos were fixed in 4% PFA + 0.1%
Tween + 0.01% Triton for 20–30 min at RT, washed three times in PBT for
Developmental Cell
Cell Competition Monitors Stem Cell Fitness5 min, and permeabilized with 0.4% Triton in PBS for 20 min. Then, TUNEL
staining was performed as indicated in the kit; once completed, embryos
were stained for c-MYC using a tyramide signal amplification system
(PerkinElmer TSA Cyanine Plus 3 Evaluation Kit) as described elsewhere
(Clements et al., 2011).
Western Blot Analysis
For the analysis of cells in cocultures, the different genotypes were separated
by FACS based on GFP expression. Cells were lysed in radio immunopre-
cipitation assay buffer containing Complete Mini Protease Inhibitors (Roche)
and Phosphatase Inhibitors Set II (Calbiochem). Protein extracts (5–40 mg)
were resolved by a 10% SDS-PAGE gel and subjected to western blot anal-
ysis. Primary antibodies used were rabbit anti-c-MYC (N-262 clone, 1:200),
rabbit anti-phospho-Smad1/5/8 (1:1,000; Cell Signaling), rabbit anti-LC3
(1:300; Abgent), mouse anti-p62 (1:1,500; BD Bioscience), (rabbit anti-PCNA
(1:5,000; Santa Cruz), and rabbit anti-tubulin (1:5,000; Cell Signaling).
For clonal assays, flow cytometry, annexin V staining, electroporation,
RNA isolation, quantitative real-time PCR, and microarray analysis, see
Supplemental Experimental Procedures.
ACCESSION NUMBERS
The GEO accession number for our microarray data is GSE48092.
SUPPLEMENTAL INFORMATION
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six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2013.06.012.
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